普昂医疗过会：今年IPO过关第107家 国金证券过4单

Group 1 - The Beijing Stock Exchange's listing committee approved the IPO of Puan (Hangzhou) Medical Technology Co., Ltd., marking it as the 107th company to pass the review this year [1][2] - Puan Medical specializes in the research, production, and sales of medical devices related to diabetes care, general drug infusion, and minimally invasive interventions [1] - The company plans to issue up to 10,582,800 shares to unspecified qualified investors, aiming to raise approximately 395.255 million yuan for various projects, including the construction of a smart manufacturing production line for interventional medical devices [2] Group 2 - The main underwriter for Puan Medical's IPO is Guojin Securities, which has successfully sponsored four IPO projects this year [1][2] - The company is controlled by Hu Chaoyu and Mao Liuying, who are husband and wife, with their combined shareholding constituting 54.67% of the total shares [2] - The review meeting raised inquiries regarding the reasonableness of the company's gross margin changes and the necessity of the fundraising projects, requesting detailed analyses and verification from the underwriters and accountants [4]